{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:10:38Z","timestamp":1789517438661,"version":"build-2803163510"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,9,7]],"date-time":"2014-09-07T00:00:00Z","timestamp":1410048000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gastric Cancer"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s10120-014-0403-x","type":"journal-article","created":{"date-parts":[[2014,9,6]],"date-time":"2014-09-06T01:54:18Z","timestamp":1409968458000},"page":"550-563","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["International comparison of the German evidence-based S3-guidelines on the diagnosis and multimodal treatment of early and locally advanced gastric cancer, including adenocarcinoma of the lower esophagus"],"prefix":"10.1007","volume":"18","author":[{"given":"Markus","family":"Moehler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph T. H.","family":"Baltin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Ebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Fischbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Gockel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Grenacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnulf H.","family":"H\u00f6lscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Lordick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Malfertheiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Messmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Joachim","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Palmqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"R\u00f6cken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Schuhmacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Stahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Stuschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Vieth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Wittekind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothea","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan P.","family":"M\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,7]]},"reference":[{"issue":"8","key":"403_CR1","doi-asserted-by":"crossref","first-page":"830","DOI":"10.6004\/jnccn.2011.0072","volume":"9","author":"JA Ajani","year":"2011","unstructured":"Ajani JA, et al. Esophageal and esophagogastric junction cancers. J Natl Compr Canc Netw. 2011;9(8):830-87.","journal-title":"J Natl Compr Canc Netw."},{"issue":"Suppl 5","key":"403_CR2","doi-asserted-by":"crossref","first-page":"v50","DOI":"10.1093\/annonc\/mdq164","volume":"21","author":"A Okines","year":"2010","unstructured":"Okines A, et al. Gastric cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(Suppl 5):v50\u20134.","journal-title":"Ann Oncol"},{"key":"403_CR3","doi-asserted-by":"crossref","unstructured":"Van Cutsem E, et al. The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO\/World Congress on Gastrointestinal Cancer, Barcelona, 2010. Ann Oncol. 2011;22(Suppl 5):v1\u20139.","DOI":"10.1093\/annonc\/mdr284"},{"key":"403_CR4","doi-asserted-by":"crossref","unstructured":"Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14(2):113\u201323.","DOI":"10.1007\/s10120-011-0042-4"},{"issue":"6","key":"403_CR5","first-page":"91e","volume":"61","author":"T Popiela","year":"2011","unstructured":"Popiela T. Polish Gastric Cancer Study Project; success or failure? Nowotwory. 2011;61(6):91e\u20133e.","journal-title":"Nowotwory"},{"key":"403_CR6","unstructured":"NCCN Guidelines\u00ae: clinical practice guidelines in oncology: esophageal and esophagogastric junction cancers V2.2013. http:\/\/nccn.org ."},{"key":"403_CR7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1055\/s-0031-1273201","volume":"49","author":"M Moehler","year":"2011","unstructured":"Moehler M, et al. S3-Leitlinie \u201cMagenkarzinom\u201d\u2014Diagnostik und Therapie der Adenokarzinome des Magens und \u00f6sophagogastralen \u00dcbergangs (AWMF-Regist.-Nr. 032-009-OL). Z Gastroenterol. 2011;49:461\u2013531.","journal-title":"Z Gastroenterol"},{"issue":"11","key":"403_CR8","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1136\/gut.2010.228254","volume":"60","author":"WH Allum","year":"2011","unstructured":"Allum WH, et al. Guidelines for the management of oesophageal and gastric cancer. Gut. 2011;60(11):1449\u201372.","journal-title":"Gut"},{"issue":"5","key":"403_CR9","doi-asserted-by":"crossref","first-page":"531","DOI":"10.6004\/jnccn.2013.0070","volume":"11","author":"JA Ajani","year":"2013","unstructured":"Ajani JA, et al. Gastric cancer, version 2.2013: featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2013;11(5):531\u201346.","journal-title":"J Natl Compr Canc Netw"},{"key":"403_CR10","unstructured":"Peeters M, et al. Een nationale praktijkrichtlijn voor de aanpak van slokdarm\u2014en maagkanker. Federaal Kenniscentrum voor de Gezondheidszorg (KCE), Brussel KCE reports. 2008; p. 75."},{"key":"403_CR11","unstructured":"Ychou M, et al. Recommandations pour la pratique clinique: standards, options et recommandations 2003 pour la prise en charge des patients atteints d\u2019 ad\u00e9nocarcinomes de l\u2019estomac. 2004. F\u00e9deration nationale des centres de lutte contre le cancer."},{"key":"403_CR12","unstructured":"SIGN: Scottish Intercollegiate Guidelines Network. Management of oesophageal and gastric cancer. 2006. http:\/\/www.sign.ac.uk\/pdf\/sign87.pdf"},{"key":"403_CR13","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1055\/s-2004-825853","volume":"36","author":"S Yalamarthi","year":"2004","unstructured":"Yalamarthi S, et al. Missed diagnoses in patients with upper gastrointestinal cancers. Endoscopy. 2004;36:874\u20139.","journal-title":"Endoscopy"},{"key":"403_CR14","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1097\/00042737-200512000-00013","volume":"17","author":"ME Voutilainen","year":"2005","unstructured":"Voutilainen ME, Juhola MT. Evaluation of the diagnostic accuracy of gastroscopy to detect gastric tumours: clinicopathological features and prognosis of patients with gastric cancer missed on endoscopy. Eur J Gastroenterol Hepatol. 2005;17:1345\u20139.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"403_CR15","first-page":"681","volume":"47","author":"A Amin","year":"2002","unstructured":"Amin A, et al. Gastric adenocarcinoma missed at endoscopy. J R Coll Surg Edinb. 2002;47:681\u20134.","journal-title":"J R Coll Surg Edinb"},{"key":"403_CR16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/00000658-199810000-00002","volume":"228","author":"JR Siewert","year":"1998","unstructured":"Siewert JR, et al. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg. 1998;228:449\u201361.","journal-title":"Ann Surg"},{"key":"403_CR17","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1055\/s-2008-1027195","volume":"29","author":"A Oldenburg","year":"2008","unstructured":"Oldenburg A, Albrecht T. Baseline and contrast-enhanced ultrasound of the liver in tumor patients. Ultraschall Med. 2008;29:488\u201398.","journal-title":"Ultraschall Med"},{"key":"403_CR18","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/jso.20819","volume":"96","author":"EP Vliet van","year":"2007","unstructured":"van Vliet EP, et al. Ultrasound, computed tomography, or the combination for the detection of supraclavicular lymph nodes in patients with esophageal or gastric cardia cancer: a comparative study. J Surg Oncol. 2007;96:200\u20136.","journal-title":"J Surg Oncol"},{"key":"403_CR19","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jamcollsurg.2008.10.022","volume":"208","author":"DG Power","year":"2009","unstructured":"Power DG, et al. Endoscopic ultrasound can improve the selection for laparoscopy in patients with localized gastric cancer. J Am Coll Surg. 2009;208:173\u20138.","journal-title":"J Am Coll Surg"},{"issue":"2","key":"403_CR20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10120-011-0040-6","volume":"14","author":"T Sano","year":"2011","unstructured":"Sano T, Aiko T. New Japanese classifications and treatment guidelines for gastric cancer: revision concepts and major revised points. Gastric Cancer. 2011;14(2):97\u2013100.","journal-title":"Gastric Cancer"},{"key":"403_CR21","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1200\/JCO.2005.19.935","volume":"23","author":"R Soetikno","year":"2005","unstructured":"Soetikno R, et al. Endoscopic mucosal resection for early cancers of the upper gastrointestinal tract. J Clin Oncol. 2005;23:4490\u20138.","journal-title":"J Clin Oncol"},{"key":"403_CR22","doi-asserted-by":"crossref","unstructured":"Sanomura Y, et al. Clinical validity of endoscopic submucosal dissection for submucosal invasive gastric cancer: a single-center study. Gastric Cancer. 2012;15(1):97\u2013105.","DOI":"10.1007\/s10120-011-0076-7"},{"key":"403_CR23","doi-asserted-by":"crossref","unstructured":"Tanaka N, et al. Trends in characteristics of surgically treated early gastric cancer patients after the introduction of gastric cancer treatment guidelines in Japan. Gastric Cancer. 2010;13(2):74\u20137.","DOI":"10.1007\/s10120-009-0536-5"},{"key":"403_CR24","doi-asserted-by":"crossref","unstructured":"Hirasawa T, et al. Lymph node metastasis from undifferentiated-type mucosal gastric cancer satisfying the expanded criteria for endoscopic resection based on routine histological examination. Gastric Cancer. 2010;13(4):267\u201370.","DOI":"10.1007\/s10120-010-0577-9"},{"key":"403_CR25","doi-asserted-by":"crossref","unstructured":"Lorenzen S, et al. Prediction of response and prognosis by a score including only pretherapeutic parameters in 410 neoadjuvant treated gastric cancer patients. Ann Surg Oncol. 2012;19(7):2119\u201327.","DOI":"10.1245\/s10434-012-2254-1"},{"key":"403_CR26","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/jso.20631","volume":"96","author":"N Shiraishi","year":"2007","unstructured":"Shiraishi N, et al. Multivariate prognostic study on large gastric cancer. J Surg Oncol. 2007;96:14\u20138.","journal-title":"J Surg Oncol"},{"key":"403_CR27","doi-asserted-by":"crossref","unstructured":"Nitti D, et al. Recent advances in conventional and molecular prognostic factors for gastric carcinoma. Surg Oncol Clin N Am. 2008;17:467\u201383, vii.","DOI":"10.1016\/j.soc.2008.02.010"},{"key":"403_CR28","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/sj.bjc.6601790","volume":"90","author":"P Edwards","year":"2004","unstructured":"Edwards P, et al. Prospective comparison of D1 vs modified D2 gastrectomy for carcinoma. Br J Cancer. 2004;90:1888\u201392.","journal-title":"Br J Cancer"},{"key":"403_CR29","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/sj.bjc.6601761","volume":"90","author":"M Degiuli","year":"2004","unstructured":"Degiuli M, et al. Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer. Br J Cancer. 2004;90:1727\u201332.","journal-title":"Br J Cancer"},{"issue":"12","key":"403_CR30","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1056\/NEJM199903253401202","volume":"340","author":"JJ Bonenkamp","year":"1999","unstructured":"Bonenkamp JJ, et al. Extended lymph-node dissection for gastric cancer. N Engl J Med. 1999;340(12):908\u201314.","journal-title":"N Engl J Med"},{"issue":"9\u201310","key":"403_CR31","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1038\/sj.bjc.6690243","volume":"79","author":"A Cuschieri","year":"1999","unstructured":"Cuschieri A, et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer. 1999;79(9\u201310):1522\u201330.","journal-title":"Br J Cancer"},{"issue":"11","key":"403_CR32","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1200\/JCO.2004.08.026","volume":"22","author":"HH Hartgrink","year":"2004","unstructured":"Hartgrink HH, et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol. 2004;22(11):2069\u201377.","journal-title":"J Clin Oncol"},{"issue":"3","key":"403_CR33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/jso.20222","volume":"90","author":"HH Hartgrink","year":"2005","unstructured":"Hartgrink HH, van de Velde CJ. Status of extended lymph node dissection: locoregional control is the only way to survive gastric cancer. J Surg Oncol. 2005;90(3):153\u201365.","journal-title":"J Surg Oncol"},{"key":"403_CR34","doi-asserted-by":"crossref","unstructured":"Songun I, et al. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11(5):439\u201349.","DOI":"10.1016\/S1470-2045(10)70070-X"},{"key":"403_CR35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa055531","volume":"355","author":"D Cunningham","year":"2006","unstructured":"Cunningham D, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11\u201320.","journal-title":"N Engl J Med"},{"key":"403_CR36","doi-asserted-by":"crossref","unstructured":"Boige V, et al. Final results of a randomized trial comparing preoperative 5-fluorouracil (F)\/cisplatin (P) to surgery alone in adenocarcinoma of stomach and lower esophagus. J Clin Oncol. 2007;25:18S.","DOI":"10.1200\/jco.2007.25.18_suppl.4510"},{"issue":"35","key":"403_CR37","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1200\/JCO.2009.26.6114","volume":"28","author":"C Schuhmacher","year":"2010","unstructured":"Schuhmacher C, et al. Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954. J Clin Oncol. 2010;28(35):5210\u20138.","journal-title":"J Clin Oncol"},{"issue":"24","key":"403_CR38","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1200\/JCO.2006.10.4760","volume":"25","author":"DP Kelsen","year":"2007","unstructured":"Kelsen DP, et al. Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer. J Clin Oncol. 2007;25(24):3719\u201325.","journal-title":"J Clin Oncol"},{"issue":"30","key":"403_CR39","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.1200\/JCO.2009.22.2083","volume":"27","author":"W Allum","year":"2009","unstructured":"Allum W, et al. Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J Clin Oncol. 2009;27(30):5062\u20137.","journal-title":"J Clin Oncol"},{"issue":"3","key":"403_CR40","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1470-2045(07)70039-6","volume":"8","author":"V Gebski","year":"2007","unstructured":"Gebski V, et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol. 2007;8(3):226\u201334.","journal-title":"Lancet Oncol"},{"issue":"2","key":"403_CR41","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0002-9610(02)00795-X","volume":"183","author":"J Urschel","year":"2002","unstructured":"Urschel J, Vasan H, Blewett C. A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer. Am J Surg. 2002;183(2):274\u20138.","journal-title":"Am J Surg"},{"issue":"5","key":"403_CR42","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.canrad.2008.02.002","volume":"12","author":"G Crehange","year":"2008","unstructured":"Crehange G, et al. Resectable adenocarcinoma of the oesophagogastric junction care: which perioperative treatment? Cancer Radiother. 2008;12(5):365\u201373.","journal-title":"Cancer Radiother"},{"issue":"9","key":"403_CR43","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/annonc\/mdp047","volume":"20","author":"A Okines","year":"2009","unstructured":"Okines A, et al. Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer. Ann Oncol. 2009;20(9):1529\u201334.","journal-title":"Ann Oncol"},{"issue":"27","key":"403_CR44","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1056\/NEJM199812313392704","volume":"339","author":"D Kelsen","year":"1998","unstructured":"Kelsen D, et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med. 1998;339(27):1979\u201384.","journal-title":"N Engl J Med"},{"issue":"7","key":"403_CR45","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1056\/NEJM199608153350702","volume":"335","author":"T Walsh","year":"1996","unstructured":"Walsh T, et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 1996;335(7):462\u20137.","journal-title":"N Engl J Med"},{"issue":"2","key":"403_CR46","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1200\/JCO.2001.19.2.305","volume":"19","author":"S Urba","year":"2001","unstructured":"Urba S, et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol. 2001;19(2):305\u201313.","journal-title":"J Clin Oncol"},{"issue":"9","key":"403_CR47","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S1470-2045(05)70288-6","volume":"6","author":"B Burmeister","year":"2005","unstructured":"Burmeister B, et al. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol. 2005;6(9):656\u201368.","journal-title":"Lancet Oncol"},{"issue":"7","key":"403_CR48","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1200\/JCO.2007.12.9593","volume":"26","author":"J Tepper","year":"2008","unstructured":"Tepper J, et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol. 2008;26(7):1086\u201392.","journal-title":"J Clin Oncol"},{"key":"403_CR49","doi-asserted-by":"crossref","unstructured":"Fiorica F, et al. Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis Gut. 2004;53(7):925\u201330.","DOI":"10.1136\/gut.2003.025080"},{"issue":"3","key":"403_CR50","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.radonc.2006.01.009","volume":"78","author":"J Geh","year":"2006","unstructured":"Geh J, et al. Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: evidence of a radiation and chemotherapy dose response. Radiother Oncol. 2006;78(3):236\u201344.","journal-title":"Radiother Oncol"},{"key":"403_CR51","doi-asserted-by":"crossref","unstructured":"Malthaner R, et al. Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis. BMC Med. 2004;2(35). http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC529457\/pdf\/1741-7015-2-35.pdf .","DOI":"10.1186\/1741-7015-2-35"},{"key":"403_CR52","doi-asserted-by":"crossref","unstructured":"Urschel J, Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer Am J Surg. 2003;185(6):538\u201343.","DOI":"10.1016\/S0002-9610(03)00066-7"},{"issue":"5","key":"403_CR53","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0360-3016(98)00280-6","volume":"42","author":"Z Zhang","year":"1998","unstructured":"Zhang Z, et al. Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of gastric cardia (AGC)\u2013report on 370 patients. Int J Radiat Oncol Biol Phys. 1998;42(5):929\u201334.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"403_CR54","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1200\/JCO.2008.17.0506","volume":"27","author":"M Stahl","year":"2009","unstructured":"Stahl M, et al. Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol. 2009;27(6):851\u20136.","journal-title":"J Clin Oncol"},{"key":"403_CR55","doi-asserted-by":"crossref","unstructured":"van Hagen P, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 366(22):2074\u201384.","DOI":"10.1056\/NEJMoa1112088"},{"issue":"1","key":"403_CR56","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijrobp.2008.04.033","volume":"73","author":"RD Hofheinz","year":"2009","unstructured":"Hofheinz RD, et al. Oxaliplatin and capecitabine-based chemoradiotherapy for gastric cancer\u2014an extended phase I MARGIT and AIO trial. Int J Radiat Oncol Biol Phys. 2009;73(1):142\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"403_CR57","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/ijc.27718","volume":"132","author":"VK Ho","year":"2013","unstructured":"Ho VK, Damhuis RA, Hartgrink HH. Adherence to national guidelines for gastric cancer in the Netherlands: a retrospective population-based audit. Int J Cancer. 2013;132(5):1156\u201361.","journal-title":"Int J Cancer"},{"issue":"7","key":"403_CR58","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.ejso.2010.05.006","volume":"36","author":"T Holmebakk","year":"2010","unstructured":"Holmebakk T, Frykholm G, Viste A. Introducing national guidelines on perioperative chemotherapy for gastric cancer in Norway: a retrospective audit. Eur J Surg Oncol. 2010;36(7):610\u20136.","journal-title":"Eur J Surg Oncol"},{"key":"403_CR59","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/1471-2407-11-329","volume":"11","author":"JL Dikken","year":"2011","unstructured":"Dikken JL, et al. Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS). BMC Cancer. 2011;11:329.","journal-title":"BMC Cancer"},{"key":"403_CR60","doi-asserted-by":"crossref","unstructured":"Messager M, et al. The impact of perioperative chemotherapy on survival in patients with gastric signet ring cell adenocarcinoma: a multicenter comparative study. Ann Surg. 2011;254(5):684\u201393 (discussion 693).","DOI":"10.1097\/SLA.0b013e3182352647"},{"key":"403_CR61","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/1471-2407-13-281","volume":"13","author":"G Piessen","year":"2013","unstructured":"Piessen G, et al. Phase II\/III multicentre randomised controlled trial evaluating a strategy of primary surgery and adjuvant chemotherapy versus peri-operative chemotherapy for resectable gastric signet ring cell adenocarcinomas\u2014PRODIGE 19\u2013FFCD1103\u2013ADCI002. BMC Cancer. 2013;13:281.","journal-title":"BMC Cancer"},{"issue":"3","key":"403_CR62","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM199707173370304","volume":"337","author":"J Bosset","year":"1997","unstructured":"Bosset J, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med. 1997;337(3):161\u20137.","journal-title":"N Engl J Med"},{"issue":"6","key":"403_CR63","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1007\/BF02067069","volume":"16","author":"K Nygaard","year":"1992","unstructured":"Nygaard K, et al. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg. 1992;16(6):1104\u20139.","journal-title":"World J Surg"},{"key":"403_CR64","doi-asserted-by":"crossref","unstructured":"Ronellenfitsch U, et al. Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus. Cochrane Database Syst Rev. 2013;5:Cd008107.","DOI":"10.1002\/14651858.CD008107.pub2"}],"container-title":["Gastric Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-014-0403-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10120-014-0403-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-014-0403-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T12:02:17Z","timestamp":1650110537000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10120-014-0403-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,7]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["403"],"URL":"https:\/\/doi.org\/10.1007\/s10120-014-0403-x","relation":{},"ISSN":["1436-3291","1436-3305"],"issn-type":[{"value":"1436-3291","type":"print"},{"value":"1436-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,7]]}}}